rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Immatics N.V. -

IMTX · Nasdaq

Health CareBiotechnologyNot moving yet

IMTX stood above a rising 150-day average in 32 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 30.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 20
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$15.0M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
78 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 32 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$14.5MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Perceptive Advisors LlcDirectorbought863,060at $8.6926 Aug 2026filed 27 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders78-1 on the quarter
New · exited12 · 13
Reported value$778.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
RTW INVESTMENTS, LPadded · filed 14 Aug 202612,946,176$131.1M+76,836+0.6%
MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 202611,190,129$113.4M00.0%
PERCEPTIVE ADVISORS LLCunchanged · filed 14 Aug 202610,383,456$105.2M00.0%
BAKER BROS. ADVISORS LPreduced · filed 14 Aug 20269,508,565$96.3M-1,408,128−12.9%
Jefferies Financial Group Inc.added · filed 17 Aug 20266,506,802$65.9M+1,447,251+28.6%
Vestal Point Capital, LPunchanged · filed 14 Aug 20266,175,000$62.6M00.0%
Sofinnova Investments, Inc.added · filed 14 Aug 20263,669,346$37.2M+38,892+1.1%
MORGAN STANLEYadded · filed 13 Aug 20262,186,494$22.1M+37,412+1.7%
CITADEL ADVISORS LLCreduced · filed 14 Aug 20261,814,657$18.4M-37,306−2.0%
WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 20261,647,852$16.7M+85,960+5.5%
31 Mar 2023 – 30 Jun 2026
536882Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Joseph Edelman Company insiderDirector · last 26 Aug 20261 · 0
PERCEPTIVE ADVISORS LLC Company insiderDirector · last 26 Aug 20261 · 0
James Nelson Pepin Company insiderGen Counsel and Corp Secretary · last 14 Aug 20260 · 0
Adam Leo Stone Company insiderDirector · last 16 Jun 20260 · 0
Alise Reicin Company insiderDirector · last 16 Jun 20260 · 0
Eliot Forster Company insiderDirector · last 16 Jun 20260 · 0
Heather L. Mason Company insiderDirector · last 16 Jun 20260 · 0
Mathias Hothum Company insiderDirector · last 16 Jun 20260 · 0
Michael G. Atieh Company insiderDirector · last 16 Jun 20260 · 0
Paul Rutherford Carter Company insiderDirector · last 16 Jun 20260 · 0
Peter Alan Chambre Company insiderDirector · last 16 Jun 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 202510.3%

Analyst forecasts

No analyst forecasts yet.